Kevin C. Glenn, Ph.D.

Kevin C. Glenn, Ph.D.

Allergenicity/Pipeline Issues Mgmt Lead, Monsanto Company

Dr. Kevin Glenn is a Monsanto Senior Science Fellow and the Scientific Affairs Pipeline Lead within Monsanto Regulatory. He is author of more than 62 scientific publications and 22 patents, a co-inventor of two cholesterol improving therapeutics, and also the co-inventor of a wound-healing agent.

Dr. Glenn obtained his B.S. degree in microbiology from the California State Polytechnic University, Pomona, and his Ph.D. in cell biology from the University of California, Irvine. He joined Monsanto in 1983 after completing an American Heart Association postdoctoral research fellowship at the University of Washington, Seattle. At Monsanto, he has held several roles, including Acting Director of Cardiovascular Research for G.D. Searle.

Dr. Glenn is past Chair of the International Food Biotechnology Committee of the International Life Sciences Institute (ILSI). Previously he chaired the ILSI Task Force on Nutritional and Safety Assessments of GM Crops and the Subcommittee on DNA/Protein Detection within the industry-wide Agricultural Biotechnology Stewardship Technical Committee (ABSTC).

From this Expert

Posted on March 2, 2017
Response from Kevin C. Glenn, Ph.D., Allergenicity/Pipeline Issues Mgmt Lead, Monsanto Company • August 22, 2017
The term “GMO” typically refers to crops or animals that, through genetic engineering, have had a gene (or a few genes) from a different species inserted into their genome. So yes, by design, to improve a crop or animal with genetic engineering, the genome of the new, GE variety has been changed by the addition of new genes(s).     Your question also asks about whether inserting the new gene(s) will “…activate genes…” Some traits in... Read More
Posted on May 3, 2016
Response from Kevin C. Glenn, Ph.D., Allergenicity/Pipeline Issues Mgmt Lead, Monsanto Company • June 1, 2016
Yes, there are some published examples of GMO products that, during development, had data collected that stopped further development. One early example was the identification of a Brazil nut protein that, when expressed in soybeans, improved their nutritional quality (increased methionine, an essential amino acid for mammals). This product was never commercialized when it was learned that this protein is associated with Brazil nut food allergic reactions (Nordlee, et al, 1996).  ... Read More
No Studies were Found.